Vermont Dental Conference

Program #4 Xerostomia: Etiology, Evaluation, and Innovative Strategies

Jo-Anne Jones, RDH   Educational Sponsor (in part): 3M    
Audience Code: D, H, A        3 CEUs/Clinical Lecture 

Xerostomia or dryness of the oral cavity is now affecting 1 out of every 5 adults and has become one of the most common oral health pathologies. There are over 1100 drugs which contribute to this oral condition. Also advances in medicine and therapeutic modalities have resulted in a steadily increasing human life expectancy. With longevity we can expect salivary hypofunction. The rapid rise in diabetes and autoimmune disorders only further magnifies this oral condition and warrants the need for effective and innovative strategies.

As the population ages and the ‘silver tsunami’ rolls in, are we prepared to address the challenging condition of xerostomia? Learn how to identify and evaluate salivary hypofunction, recommend effective self-care measures, and provide new and innovative solutions that work! Participants will engage in a ‘live study’ demonstrating risk assessment for clinical practice and a ‘myth-buster’ breakout session.

LEARNING OUTCOMES:

  • To define normal salivary function vs. xerostomia conditions
  • To apply evaluative salivary assessment into clinical practice
  • To understand the prevalence and etiology of xerostomia related to today’s population
  • To effectively treat the xerostomia patient with innovative strategies to employ chairside and at home
  • To be equipped with clinical resources to aid in treatment and education
SEE HANDOUT PAGE for ATTENDEE LECTURE MATERIAL (available in September)
"State":"VT"